Literature DB >> 15936729

Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample.

Ralph E Hoffman1, Ralitza Gueorguieva, Keith A Hawkins, Maxine Varanko, Nash N Boutros, Yu-te Wu, Kathleen Carroll, John H Krystal.   

Abstract

BACKGROUND: Auditory hallucinations are often resistant to treatment and can produce significant distress and behavioral difficulties. A preliminary report based on 24 patients with schizophrenia or schizoaffective disorder indicated greater improvement in auditory hallucinations following 1-hertz left temporoparietal repetitive transcranial magnetic stimulation (rTMS) compared to sham stimulation. Data from the full 50-subject sample incorporating 26 new patients are now presented to more comprehensively assess safety/tolerability, efficacy and moderators of this intervention.
METHODS: Right-handed patients experiencing auditory hallucinations at least 5 times per day were randomly allocated to receive either rTMS or sham stimulation. A total of 132 minutes of rTMS was administered over 9 days at 90% motor threshold using a double-masked, sham-controlled, parallel design.
RESULTS: Hallucination Change Score was more improved for rTMS relative to sham stimulation (p = .008) as was the Clinical Global Impressions Scale (p = .0004). Hallucination frequency was significantly decreased during rTMS relative to sham stimulation (p = .0014) and was a moderator of rTMS effects (p = .008). There was no evidence of neurocognitive impairment associated with rTMS.
CONCLUSIONS: Left temporoparietal 1-hertz rTMS warrants further study as an intervention for auditory hallucinations. Data suggest that this intervention selectively alters neurobiological factors determining frequency of these hallucinations.

Entities:  

Mesh:

Year:  2005        PMID: 15936729     DOI: 10.1016/j.biopsych.2005.03.041

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  71 in total

1.  [Current trends in the therapy of tinnitus. The search for the philosopher's stone].

Authors:  W Delb
Journal:  HNO       Date:  2010-11       Impact factor: 1.284

Review 2.  Transcranial magnetic simulation in the treatment of migraine.

Authors:  Richard B Lipton; Starr H Pearlman
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

3.  Is there evidence for effectiveness of transcranial magnetic stimulation in the treatment of psychiatric disorders?

Authors:  Biju Basil; Jamal Mahmud; Maju Mathews; Carlos Rodriguez; Babatunde Adetunji
Journal:  Psychiatry (Edgmont)       Date:  2005-11

4.  Neuromodulation and Transcranial Mag Netic Stimulation (TMS): A 21st Century Paradigm for Therapeutics in Psychiatry.

Authors:  John P O'Reardon; Andrew D Peshek; Rocio Romero; Pilar Cristancho
Journal:  Psychiatry (Edgmont)       Date:  2006-01

5.  High-frequency priming stimulation does not enhance the effect of low-frequency rTMS in the treatment of tinnitus.

Authors:  Berthold Langguth; Tobias Kleinjung; Elmar Frank; Michael Landgrebe; Philipp Sand; Jana Dvorakova; Ulrich Frick; Peter Eichhammer; Göran Hajak
Journal:  Exp Brain Res       Date:  2007-12-07       Impact factor: 1.972

Review 6.  rTMS strategies for the study and treatment of schizophrenia: a review.

Authors:  Arielle D Stanford; Zafar Sharif; Cheryl Corcoran; Nina Urban; Dolores Malaspina; Sarah H Lisanby
Journal:  Int J Neuropsychopharmacol       Date:  2008-02-01       Impact factor: 5.176

7.  Study on the behavioral changes of a post-stroke depression rat model.

Authors:  Chunfang Wu; Junhe Zhang; Yong Chen
Journal:  Exp Ther Med       Date:  2015-04-24       Impact factor: 2.447

Review 8.  Converging effects of diverse treatment modalities on frontal cortex in schizophrenia: A review of longitudinal functional magnetic resonance imaging studies.

Authors:  Ayse Sakalli Kani; Ann K Shinn; Kathryn E Lewandowski; Dost Öngür
Journal:  J Psychiatr Res       Date:  2016-10-19       Impact factor: 4.791

Review 9.  The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.

Authors:  Robert W Buchanan; Julie Kreyenbuhl; Deanna L Kelly; Jason M Noel; Douglas L Boggs; Bernard A Fischer; Seth Himelhoch; Beverly Fang; Eunice Peterson; Patrick R Aquino; William Keller
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

Review 10.  Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research.

Authors:  Simone Rossi; Mark Hallett; Paolo M Rossini; Alvaro Pascual-Leone
Journal:  Clin Neurophysiol       Date:  2009-10-14       Impact factor: 3.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.